Schwartz Phillip
- SEC CIK
- 0001766208
No open-market purchases or sales filed in the past year.
Current role at each company
- ENTX Entera Bio Ltd.President of R&Das of Jan 24, 2022
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Schwartz Phillip as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jan 24, 2022 (view filing) | Jan 20 | 4 days | Schwartz PhillipPresident of R&D | PPurchaseOrdinary Shares, par value NIS 0.0000769 per share | +10.0K | $2.53 | +$25.3K | +1.7%607.4K after |